Cerbomed at the INS 10th World Congress

(openPR) ERLANGEN, Germany, 17.05.2011 – The medical device company cerbomed GmbH is proud to present NEMOS, the world’s first medical device for transcutaneous Vagus Nerve Stimulation (t-VNS), at the 10. World Congress of the International Neuromodulation Society in London.
Please save May 25th and use the chance to get additional information about t-VNS at the INS Classroom Session at 11.35 a.m. and at two poster presentations.

About NEMOS
NEMOS is intended for people suffering from various difficult to treat neurological and psychiatric diseases. The current lead indications are drug-resistant epilepsies. Further indications such as chronic pain, tinnitus and schizophrenia are currently being evaluated in clinical studies.
Cerbomed’s t-VNS therapy uses the fact that a branch of the vagus nerve is located directly under the skin in areas of the outer ear and that nerves can be stimulated through the skin (transcutaneously) with electrical impulses. NEMOS consists of a stimulation unit and an ear electrode which the patient wears in the ear like an earphone for 3 to 5 hours per day.
Cerbomed expects NEMOS to offer a highly attractive and cost-effective alternative to current and emerging VNS treatments, other neurostimulation methods, surgery or pharmacologic therapies. These therapeutic alternatives are connected either with higher risks or have undesirable side effects. Such alternatives are also often considerably less effective and more expensive.